Epigenetics in SLE

Overview

Journal Curr Rheumatol Rep

Publisher Current Science

Specialty Rheumatology

Date 2017 Jul 29

PMID 28752494

Citations 44

Authors

Christian Michael Hedrich

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Systemic lupus erythematosus is a severe autoimmune/inflammatory condition of unknown pathophysiology. Though genetic predisposition is essential for disease expression, risk alleles in single genes are usually insufficient to confer disease. Epigenetic dysregulation has been suggested as the missing link between genetic risk and the development of clinically evident disease.

Recent Findings: Over the past decade, epigenetic events moved into the focus of research targeting the molecular pathophysiology of SLE. Epigenetic alteration can be the net result of preceding infections, medication, diet, and/or other environmental influences. While altered DNA methylation and histone modifications had already been established as pathomechanisms, DNA hydroxymethylation was more recently identified as an activating epigenetic mark. Defective epigenetic control contributes to uncontrolled cytokine and co-receptor expression, resulting in immune activation and tissue damage in SLE. Epigenetic alterations promise potential as disease biomarkers and/or future therapeutic targets in SLE and other autoimmune/inflammatory conditions.

Citing Articles

Lupus and other autoimmune diseases: Epidemiology in the population of African ancestry and diagnostic and management challenges in Africa.

Essouma M, Noubiap J J Allergy Clin Immunol Glob. 2024; 3(4):100288.

PMID: 39282618 PMC: 11399606. DOI: 10.1016/j.jacig.2024.100288.

Role of histone deacetylase inhibitors in non-neoplastic diseases.

Zhou C, Zhao D, Wu C, Wu Z, Zhang W, Chen S Heliyon. 2024; 10(13):e33997.

PMID: 39071622 PMC: 11283006. DOI: 10.1016/j.heliyon.2024.e33997.

Genetic interrogation for sequence and copy number variants in systemic lupus erythematosus.

Yeo N, Lim C, Yaung K, Khoo N, Arkachaisri T, Albani S Front Genet. 2024; 15:1341272.

PMID: 38501057 PMC: 10944961. DOI: 10.3389/fgene.2024.1341272.

Dissecting the Immune System through Gene Regulation.

Yoshida H Adv Exp Med Biol. 2024; 1444:219-235.

PMID: 38467983 DOI: 10.1007/978-981-99-9781-7_15.

Study of MicroRNA-124 in Patients with Lupus Nephritis.

Abdelsalam M, Zaki M, Abo El-Kheir N, Salama M, Osman A Endocr Metab Immune Disord Drug Targets. 2024; 24(10):1180-1185.

PMID: 38317459 DOI: 10.2174/0118715303250919231010073608.

References

Rauen T, Hedrich C, Tenbrock K, Tsokos G . cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med. 2013; 19(4):262-9. PMC: 3891595. DOI: 10.1016/j.molmed.2013.02.001. View

Song C, Szulwach K, Fu Y, Dai Q, Yi C, Li X . Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol. 2010; 29(1):68-72. PMC: 3107705. DOI: 10.1038/nbt.1732. View

Nakkuntod J, Avihingsanon Y, Mutirangura A, Hirankarn N . Hypomethylation of LINE-1 but not Alu in lymphocyte subsets of systemic lupus erythematosus patients. Clin Chim Acta. 2011; 412(15-16):1457-61. DOI: 10.1016/j.cca.2011.04.002. View

Hofmann S, Moller J, Rauen T, Paul D, Gahr M, Rosen-Wolff Z . Dynamic CpG-DNA methylation of Il10 and Il19 in CD4+ T lymphocytes and macrophages: effects on tissue-specific gene expression. Klin Padiatr. 2011; 224(2):53-60. DOI: 10.1055/s-0031-1291359. View

Pernis A . Estrogen and CD4+ T cells. Curr Opin Rheumatol. 2007; 19(5):414-20. DOI: 10.1097/BOR.0b013e328277ef2a. View

Schoggins J, Wilson S, Panis M, Murphy M, Jones C, Bieniasz P . A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011; 472(7344):481-5. PMC: 3409588. DOI: 10.1038/nature09907. View

Gorelik G, Fang J, Wu A, Sawalha A, Richardson B . Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol. 2007; 179(8):5553-63. DOI: 10.4049/jimmunol.179.8.5553. View

Sunahori K, Juang Y, Tsokos G . Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J Immunol. 2009; 182(3):1500-8. PMC: 2676107. DOI: 10.4049/jimmunol.182.3.1500. View

Zhang Y, Zhao M, Sawalha A, Richardson B, Lu Q . Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun. 2013; 41:92-9. DOI: 10.1016/j.jaut.2013.01.005. View

10.

Soumyanarayanan U, Dymock B . Recently discovered EZH2 and EHMT2 (G9a) inhibitors. Future Med Chem. 2016; 8(13):1635-54. DOI: 10.4155/fmc-2016-0096. View

11.

Sunahori K, Nagpal K, Hedrich C, Mizui M, Fitzgerald L, Tsokos G . The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway.... J Biol Chem. 2013; 288(30):21936-44. PMC: 3724648. DOI: 10.1074/jbc.M113.467266. View

12.

Liu Y, Kuick R, Hanash S, Richardson B . DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol. 2008; 130(2):213-24. PMC: 2655730. DOI: 10.1016/j.clim.2008.08.009. View

13.

Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J . Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell. 2011; 42(4):451-64. PMC: 3099128. DOI: 10.1016/j.molcel.2011.04.005. View

14.

Lian X, Xiao R, Hu X, Kanekura T, Jiang H, Li Y . DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum. 2012; 64(7):2338-45. DOI: 10.1002/art.34376. View

15.

Renauer P, Coit P, Jeffries M, Merrill J, McCune W, Maksimowicz-McKinnon K . DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus. Lupus Sci Med. 2015; 2(1):e000101. PMC: 4577980. DOI: 10.1136/lupus-2015-000101. View

16.

Tsokos G . Systemic lupus erythematosus. N Engl J Med. 2011; 365(22):2110-21. DOI: 10.1056/NEJMra1100359. View

17.

Neri F, Incarnato D, Krepelova A, Rapelli S, Pagnani A, Zecchina R . Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol. 2013; 14(8):R91. PMC: 4053938. DOI: 10.1186/gb-2013-14-8-r91. View

18.

Strickland F, Hewagama A, Wu A, Sawalha A, Delaney C, Hoeltzel M . Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. Arthritis Rheum. 2013; 65(7):1872-81. PMC: 3735138. DOI: 10.1002/art.37967. View

19.

Lu J, Clark A . Impact of microRNA regulation on variation in human gene expression. Genome Res. 2012; 22(7):1243-54. PMC: 3396366. DOI: 10.1101/gr.132514.111. View

20.

Renaudineau Y, Youinou P . Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med. 2011; 60(1):10-6. DOI: 10.2302/kjm.60.10. View